Cargando…
Platelet biomarkers for a descending cognitive function: A proteomic approach
Memory loss is the most common clinical sign in Alzheimer's disease (AD); thus, searching for peripheral biomarkers to predict cognitive decline is promising for early diagnosis of AD. As platelets share similarities to neuron biology, it may serve as a peripheral matrix for biomarkers of neuro...
Autores principales: | Yu, Haitao, Liu, Yanchao, He, Benrong, He, Ting, Chen, Chongyang, He, Jiahua, Yang, Xifei, Wang, Jian‐Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135080/ https://www.ncbi.nlm.nih.gov/pubmed/33942972 http://dx.doi.org/10.1111/acel.13358 |
Ejemplares similares
-
Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients
por: Yu, Haitao, et al.
Publicado: (2021) -
Discovering new peripheral plasma biomarkers to identify cognitive decline in type 2 diabetes
por: Yu, Haitao, et al.
Publicado: (2022) -
Recombinant human erythropoietin ameliorates cognitive dysfunction of APP/PS1 mice by attenuating neuron apoptosis via HSP90β
por: Wan, Hua-Li, et al.
Publicado: (2022) -
Integrated analyses of brain and platelet omics reveal their common altered and driven molecules in Alzheimer's disease
por: Yu, Haitao, et al.
Publicado: (2022) -
Periphery Biomarkers for Objective Diagnosis of Cognitive Decline in Type 2 Diabetes Patients
por: Liu, Yanchao, et al.
Publicado: (2021)